Martin Shkreli's Turing Pharmaceuticals had quite a moment of infamy this week when, thinking they had cornered the market on a drug called Daraprim, the company sent its own stock price soaring by announcing it would raise the price of the drug from $13.50 per pill to $750.00 (!). Naturally, this gave rise to all kinds of denounciations from politicians and the media, along with claims that this sort of thing is exactly why we need government price controls - because otherwise we would all be helpless before the whims of capitalist madmen like Shkreli.